Capitolis Liquid Global Markets LLC Purchases Shares of 333,627 Corteva, Inc. $CTVA

Capitolis Liquid Global Markets LLC acquired a new position in Corteva, Inc. (NYSE:CTVAFree Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 333,627 shares of the company’s stock, valued at approximately $22,363,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Concentric Capital Strategies LP acquired a new position in Corteva in the fourth quarter worth $471,000. Balyasny Asset Management L.P. boosted its stake in Corteva by 88.4% in the fourth quarter. Balyasny Asset Management L.P. now owns 10,112 shares of the company’s stock worth $678,000 after purchasing an additional 4,745 shares in the last quarter. Banco Bilbao Vizcaya Argentaria S.A. boosted its stake in Corteva by 4.3% in the fourth quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 212,879 shares of the company’s stock worth $14,271,000 after purchasing an additional 8,873 shares in the last quarter. Align Financial LLC acquired a new position in shares of Corteva during the fourth quarter valued at $809,000. Finally, American Trust lifted its stake in shares of Corteva by 11.4% during the fourth quarter. American Trust now owns 3,497 shares of the company’s stock valued at $234,000 after acquiring an additional 357 shares during the period. Institutional investors and hedge funds own 81.54% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on CTVA. Argus upped their price target on Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a research note on Tuesday, March 31st. Morgan Stanley upped their price target on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 28th. BNP Paribas Exane upped their price target on Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Oppenheimer upped their price target on Corteva from $86.00 to $89.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. Finally, Wells Fargo & Company upped their price objective on Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a report on Tuesday, April 21st. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $88.81.

View Our Latest Report on Corteva

Corteva Trading Up 0.7%

NYSE CTVA opened at $77.45 on Thursday. The stock has a 50-day simple moving average of $79.88 and a 200 day simple moving average of $75.59. The company has a market capitalization of $51.80 billion, a PE ratio of 45.56, a P/E/G ratio of 2.35 and a beta of 0.57. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $85.63.

Corteva (NYSE:CTVAGet Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. During the same period in the prior year, the company earned $1.13 earnings per share. The company’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts forecast that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were issued a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date was Monday, June 1st. Corteva’s dividend payout ratio is 42.35%.

Corteva Company Profile

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Read More

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.